The Johns Hopkins professor and new MHE editorial advisory board member lauds the effects of the Affordable Care Act but holds out for a program that “gets every human being the healthcare that every human being deserves,” in this second part of a four-part series.
Democracy is the worst form of government — except for all the others. So the saying goes.
Otis Brawley’s opinion of the Affordable Care Act is similar.
“Is the Affordable Care Act perfect? Absolutely not. It is better than almost anything I have seen so far,” Brawley said in a recent video interview with Managed Healthcare Executive® editors, Briana Contreras and Peter Wehrwein.
Brawley, a professor of oncology and epidemiology at Johns Hopkins and former chief medical and scientific officer for the American Cancer Society, recently joined the MHE’s editorial advisory board.
In a wide-ranging conversation with Contreras and Wehrwein, Brawley’s qualified endorsement of the ACA came with observations about the law’s positive effects — and pointed criticisms of its opponents.
Related: Otis Brawley’s Split Screen: Racism, Lack of Caring — But Hope in the Response
“There are a number of studies out there that demonstrate that people are not dying because of the Affordable Care Act,” Brawley said. “There are a number of studies out there that demonstrate that people are not suffering because of the Affordable Care Act. By the same token, there are studies out there that indicate that there is more death and more suffering in states that have not expanded Medicaid under the Affordable Care Act versus the states that have. All the studies are out there.”
Brawley noted that other large federal government programs, such as Social Security and Medicare, have been continually revised since they were enacted.
“The Affordable Care Act was instituted a little over 10 years ago and it has not had the opportunity to be tweaked and changes and modified because one party keeps on saying, ‘no.’”
Brawley had some barbed observations about states that haven’t expanded Medicaid. “The places have not expanded Medicaid under the Affordable Care Act— those are states that weren’t doing very well with health care to begin with. Interestingly, they are frequently red states. That is interesting conversation. Why is it states where people don’t seem to care about each other tend to be overwhelmingly Republican? That is an interesting question.”
Still, Brawley said he is not necessarily pro Affordable Care Act, and he spoke of an ideal: “I am pro some program or series of programs that gets every human being the health care that every human being deserves.” He staked out a similar position on Medicare for all: “What I am in favor of is all people having access to health care.”
Prevention Could Cut Global Cancer Deaths in Half
June 30th 2025According to the latest edition of The Cancer Atlas, lower-income nations are experiencing a rise in lung, colorectal and breast cancer incidence due to increasing adoption of behaviors associated with economic development—such as tobacco use, poor nutrition and physical inactivity.
Read More
Attacking PRPS Enzymes Offers Hope for Treating Fast-Growing Myc-Driven Lymphomas
June 10th 2025Researchers found that altering key enzymes involved in redox balance could disrupt the metabolism of Myc-driven lymphomas, which offers a potential new strategy to treat aggressive cancers.
Read More
Using the 'Pathway' Approach to Shorten the Time Between Cancer Diagnosis and Treatment
November 16th 2022In this episode of Tuning In to the C-Suite, Briana Contreras, editor with Managed Healthcare Executive spoke with Dr. Yuri Fesko, oncologist and vice president of Medical Affairs at Quest Diagnostics. In the conversation, Dr. Fesko addressed the ongoing issue of long gaps of times between receiving a diagnosis for a type of cancer and finally getting the treatment for it. Dr. Fesko shared the benefits a number of sectors receive when treating patients sooner and the steps to get there.
Listen
The First Financial Toxicity Tumor Board Reports Success in Individual Patient Savings
May 14th 2025Financial toxicity can affect patient outcomes and quality of life. For example, a patient may forgo treatment or medications to save money, or they may incur high medical debt or go into bankruptcy to pay for medical care.
Read More
Survey Reveals Cancer Doctors Struggle to Keep Up as Treatments Advance Quickly
May 11th 2025A new survey by Johnson & Johnson revealed that oncologists are overwhelmed by the rapid pace of innovation in cancer care, with many calling for better tools, education and collaboration to help integrate new treatments and technologies into everyday practice.
Read More